|
1
|
Gallagher JC and Tella SH: Controversies
in osteoporosis management: Antiresorptive therapy for preventing
bone loss: When to use one or two antiresorptive agents? Clin
Obstet Gynecol. 56:749–756. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Coughlan T and Dockery F: Osteoporosis and
fracture risk in older people. Clin Med (Lond). 14:187–191. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Zepetnek JO Totosy, Giangregorio LM and
Craven BC: Whole-body vibration as potential intervention for
people with low bone mineral density and osteoporosis: A review. J
Rehabil Res Dev. 46:529–542. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pritchard JM, Giangregorio LM, Atkinson
SA, Beattie KA, Inglis D, Ioannidis G, Gerstein H, Punthakee Z,
Adachi JD and Papaioannou A: Changes in trabecular bone
microarchitecture in postmenopausal women with and without type 2
diabetes: A two year longitudinal study. BMC Musculoskelet Disord.
14:1142013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
MacIntyre NJ, Adachi JD and Webber CE: In
vivo measurement of apparent trabecular bone structure of the
radius in women with low bone density discriminates patients with
recent wrist fracture from those without fracture. J Clin Densitom.
6:35–43. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang X, Good LE, Spinka R and Schnatz PF:
Osteoporosis screening in postmenopausal women aged 50–64 years:
BMI alone compared with current screening tools. Maturitas.
83:59–64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Looker AC, Melton LJ III, Harris TB,
Borrud LG and Shepherd JA: Prevalence and trends in low femur bone
density among older US adults: NHANES 2005–2006 compared with
NHANES III. J Bone Miner Res. 25:64–71. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Holvik K, Ahmed LA, Forsmo S, Gjesdal CG,
Grimnes G, Samuelsen SO, Schei B, Blomhoff R, Tell GS and Meyer HE:
No increase in risk of hip fracture at high serum retinol
concentrations in community-dwelling older Norwegians: The
Norwegian Epidemiologic Osteoporosis Studies. Am J Clin Nutr.
102:1289–1296. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hamdy RC, Baim S, Broy SB, Lewiecki EM,
Morgan SL, Tanner SB and Williamson HF: Algorithm for the
management of osteoporosis. South Med J. 103:1009–1015. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Green J, Czanner G, Reeves G, Watson J,
Wise L and Beral V: Oral bisphosphonates and risk of cancer of
oesophagus, stomach and colorectum: Case-control analysis within a
UK primary care cohort. BMJ. 341:c44442010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang WL, Sheu SY, Chen YS, Kao ST, Fu YT,
Kuo TF, Chen KY and Yao CH: Enhanced bone tissue regeneration by
porous gelatin composites loaded with the Chinese herbal decoction
Danggui Buxue Tang. PLoS One. 10:e01319992015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang G, Qin L and Shi Y:
Epimedium-derived phytoestrogen flavonoids exert beneficial effect
on preventing bone loss in late postmenopausal women: A 24-month
randomized, double-blind and placebo-controlled trial. J Bone Miner
Res. 22:1072–1079. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peng S, Zhang G, He Y, Wang X, Leung P,
Leung K and Qin L: Epimedium-derived flavonoids promote
osteoblastogenesis and suppress adipogenesis in bone marrow stromal
cells while exerting an anabolic effect on osteoporotic bone. Bone.
45:534–544. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu JH, Yao M, Ye J, Wang GD, Wang J, Cui
XJ and Mo W: Bone mass improved effect of icariin for
postmenopausal osteoporosis in ovariectomy-induced rats: A
meta-analysis and systematic review. Menopause. 23:1152–1157. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen KM, Ge BF, Ma HP, Liu XY, Bai MH and
Wang Y: Icariin, a flavonoid from the herb epimedium enhances the
osteogenic differentiation of rat primary bone marrow stromal
cells. Pharmazie. 60:939–942. 2005.PubMed/NCBI
|
|
16
|
Cao H, Ke Y, Zhang Y, Zhang CJ, Qian W and
Zhang GL: Icariin stimulates MC3T3-E1 cell proliferation and
differentiation through up-regulation of bone morphogenetic
protein-2. Int J Mol Med. 29:435–439. 2012.PubMed/NCBI
|
|
17
|
Liang W, Lin M, Li X, Li C, Gao B, Gan H,
Yang Z, Lin X, Liao L and Yang M: Icariin promotes bone formation
via the BMP-2/Smad4 signal transduction pathway in the hFOB 1.19
human osteoblastic cell line. Int J Mol Med. 30:889–895.
2012.PubMed/NCBI
|
|
18
|
Zhang Z, Xiang L, Bai D, Fu X, Wang W, Li
Y, Liu H, Pan J, Li Y, Xiao GG and Ju D: Treatment with rhizoma
dioscoreae extract has protective effect on osteopenia in
ovariectomized rats. ScientificWorldJournal.
2014:6459752014.PubMed/NCBI
|
|
19
|
de Laet CE, van der Klift M, Hofman A and
Pols HA: Osteoporosis in men and women: A story about bone mineral
density thresholds and hip fracture risk. J Bone Miner Res.
17:2231–2236. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Choi JS, Kim JW, Kim KY, Cho HR, Choi IS
and Ku SK: Antiosteoporotic effects of polycan in combination with
calcium lactate-gluconate in ovariectomized rats. Exp Ther Med.
8:957–967. 2014.PubMed/NCBI
|
|
21
|
Milat F and Ebeling PR: Osteoporosis
treatment: A missed opportunity. Med J Aust. 205:185–190. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Henriksen K, Byrjalsen I, Andersen JR,
Bihlet AR, Russo LA, Alexandersen P, Valter I, Qvist P, Lau E, Riis
BJ, et al: SMC021 Investigators: A randomized, double-blind,
multicenter, placebo-controlled study to evaluate the efficacy and
safety of oral salmon calcitonin in the treatment of osteoporosis
in postmenopausal women taking calcium and vitamin D. Bone.
91:122–129. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Strom BL, Schinnar R, Weber AL, Bunin G,
Berlin JA, Baumgarten M, DeMichele A, Rubin SC, Berlin M, Troxel AB
and Rebbeck TR: Case-control study of postmenopausal hormone
replacement therapy and endometrial cancer. Am J Epidemiol.
164:775–786. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rossing MA, Cushing-Haugen KL, Wicklund
KG, Doherty JA and Weiss NS: Menopausal hormone therapy and risk of
epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev.
16:2548–2556. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kapoor S: Icariin and its emerging role in
the treatment of osteoporosis. Chin Med J (Engl).
126:4002013.PubMed/NCBI
|
|
26
|
Luo Z, Liu M, Sun L and Rui F: Icariin
recovers the osteogenic differentiation and bone formation of bone
marrow stromal cells from a rat model of estrogen
deficiency-induced osteoporosis. Mol Med Rep. 12:382–388.
2015.PubMed/NCBI
|
|
27
|
Li CL, Liu XL, Cai WX, Lu WW, Zwahlen RA
and Zheng LW: Effect of ovariectomy on stimulating intracortical
remodeling in rats. Biomed Res Int. 2014:4214312014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Namkung-Matthai H, Appleyard R, Jansen J,
Hao Lin J, Maastricht S, Swain M, Mason RS, Murrell GA, Diwan AD
and Diamond T: Osteoporosis influences the early period of fracture
healing in a rat osteoporotic model. Bone. 28:80–86. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kubo T, Shiga T, Hashimoto J, Yoshioka M,
Honjo H, Urabe M, Kitajima I, Semba I and Hirasawa Y: Osteoporosis
influences the late period of fracture healing in a rat model
prepared by ovariectomy and low calcium diet. J Steroid Biochem Mol
Biol. 68:197–202. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park JA, Ha SK, Kang TH, Oh MS, Cho MH,
Lee SY, Park JH and Kim SY: Protective effect of apigenin on
ovariectomy-induced bone loss in rats. Life Sci. 82:1217–1223.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Johansen JS, Riis BJ, Delmas PD and
Christiansen C: Plasma BGP: An indicator of spontaneous bone loss
and of the effect of oestrogen treatment in postmenopausal women.
Eur J Clin Invest. 18:191–195. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sarvari BK, Mahadev D Sankara, Rupa S and
Mastan SA: Detection of bone metastases in breast cancer (BC)
patients by serum tartrate-resistant acid phosphatase 5b (TRACP
5b), a bone resorption marker and serum alkaline phosphatase (ALP),
a bone formation marker, in lieu of whole body skeletal
scintigraphy with Technetium99m MDP. Indian J Clin Biochem.
30:66–71. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pruessner HT: Detecting celiac disease in
your patients. Am Fam Physician. 57:1023–1034. 1998.PubMed/NCBI
|
|
34
|
Wu G, Guo JJ, Ma ZY, Wang J, Zhou ZW and
Wang Y: Correlation between calcification and bone sialoprotein and
osteopontin in papillary thyroid carcinoma. Int J Clin Exp Pathol.
8:2010–2017. 2015.PubMed/NCBI
|
|
35
|
Ek-Rylander B, Flores M, Wendel M,
Heinegard D and Andersson G: Dephosphorylation of osteopontin and
bone sialoprotein by osteoclastic tartrate-resistant acid
phosphatase. Modulation of osteoclast adhesion in vitro. J
Biol Chem. 269:14853–14856. 1994.PubMed/NCBI
|
|
36
|
Rugpolmuang L and Waikakul S: Effect of a
short-term treatment with once-a-week medication of alendronate 70
mg on bone turnover markers in postmenopausal women with
osteoporosis. J Med Assoc Thai. 98 Suppl 8:S70–S75. 2015.PubMed/NCBI
|
|
37
|
Xu F, Ding Y, Guo Y, Liu B, Kou Z, Xiao W
and Zhu J: Anti-osteoporosis effect of Epimedium via an
estrogen-like mechanism based on a system-level approach. J
Ethnopharmacol. 177:148–160. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bordinhon M, Müller SS and Silva MD:
Clinical, biomechanical and histological study on oophorectomy
induced menopause. Acta Ortop Bras. 22:260–263. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Du Z, Steck R, Doan N, Woodruff MA,
Ivanovski S and Xiao Y: Estrogen deficiency-associated bone loss in
the maxilla: A methodology to quantify the changes in the maxillary
intra-radicular alveolar bone in an ovariectomized rat osteoporosis
model. Tissue Eng Part C Methods. 21:458–466. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hattori S, Agata U, Park JH, Iimura Y,
Tokuda S, Ezawa I and Omi N: The relationship between salivary
calcium concentration and differences in bone mineral density level
in female rats. J Nutr Sci Vitaminol (Tokyo). 60:152–158. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nian H, Ma MH, Nian SS and Xu LL:
Antiosteoporotic activity of icariin in ovariectomized rats.
Phytomedicine. 16:320–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ye HY and Lou YJ: Estrogenic effects of
two derivatives of icariin on human breast cancer MCF-7 cells.
Phytomedicine. 12:735–741. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mok SK, Chen WF, Lai WP, Leung PC, Wang
XL, Yao XS and Wong MS: Icariin protects against bone loss induced
by oestrogen deficiency and activates oestrogen receptor-dependent
osteoblastic functions in UMR 106 cells. Br J Pharmacol.
159:939–949. 2010. View Article : Google Scholar : PubMed/NCBI
|
